Select Medical (NYSE:SEM) Downgraded to “Hold” Rating by Benchmark

Benchmark cut shares of Select Medical (NYSE:SEM) from a buy rating to a hold rating in a report published on Monday morning, Marketbeat Ratings reports.

A number of other analysts have also weighed in on SEM. Bank of America assumed coverage on shares of Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price on the stock. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. Finally, Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Select Medical currently has an average rating of “Hold” and a consensus price target of $40.75.

Select Medical Stock Performance

NYSE SEM opened at $38.70 on Monday. The company’s 50 day moving average is $35.19 and its 200-day moving average is $35.05. Select Medical has a 12-month low of $22.26 and a 12-month high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market cap of $5.01 billion, a P/E ratio of 18.08, a price-to-earnings-growth ratio of 1.78 and a beta of 1.42.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the firm posted $0.46 earnings per share. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. Sell-side analysts predict that Select Medical will post 2.16 earnings per share for the current year.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th will be paid a $0.125 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a yield of 1.29%. Select Medical’s dividend payout ratio is presently 23.36%.

Hedge Funds Weigh In On Select Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of SEM. Hexagon Capital Partners LLC grew its stake in Select Medical by 528.7% in the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after buying an additional 645 shares in the last quarter. Quarry LP purchased a new position in Select Medical in the 3rd quarter worth approximately $30,000. Transcendent Capital Group LLC purchased a new position in Select Medical in the 2nd quarter worth approximately $35,000. Canada Pension Plan Investment Board purchased a new stake in shares of Select Medical in the 2nd quarter valued at $39,000. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Select Medical in the 2nd quarter valued at $60,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.